Common use of Omitted Clause in Contracts

Omitted. Filed separately with the Commission. of the royalties or other revenues Licensee or Related Company received from Sublicensees other than related companies for the sale of Licensed Products or Licensed Services. Such royalties or other revenues specifically shall not include (a) payments made by a Sublicensee in consideration of equity or debt securities of Licensee; (b) payments made by a Sublicensee to support research activities to be undertaken by Licensee or Related Company; (c) payments made upon the achievement by Licensee or Related Company of specified milestones or benchmarks relating to the development of Licensed Products; (d) pilot studies; (e) performance-based milestones; (f) the license or Sublicense of any intellectual property other than Licensed Patent Rights or Technology; (g) reimbursement for patent or other expenses, or (h) the exclusive or nonexclusive regional license from Licensee to health care providers for the application of clinical screening and/or diagnosis, utilizing Licensee's proprietary technology alone or in combination with Licensed Products or Licensed Services.

Omitted. Filed separately with the Commission. of the royalties or other revenues Licensee or Related Company received receives from Sublicensees Sublicenses other than related companies from Related Companies for the sale of Licensed Products or Licensed Services. Such royalties or other revenues specifically shall not include (a) payments made by a Sublicensee in consideration of equity or debt securities of Licensee; (b) payments made by a Sublicensee to support research activities to be undertaken by Licensee or Related CompanyLicensee; (c) payments made upon the achievement by Licensee or and Related Company of specified milestones or benchmarks relating to the development of Licensed Products; (d) pilot studies; (e) performance-based milestones; (f) the license or Sublicense of any intellectual property other than Licensed Patent Rights or Technology; (g) reimbursement for patent or other expenses, or (h) the exclusive or nonexclusive regional license from Licensee to health care providers for the application of clinical screening and/or diagnosis, utilizing Licensee's proprietary technology alone or in combination with a Licensed Products Product or Licensed ServicesService.